<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03436004</url>
  </required_header>
  <id_info>
    <org_study_id>ENDOCOLES</org_study_id>
    <nct_id>NCT03436004</nct_id>
  </id_info>
  <brief_title>Evaluation of Colonoscopy With a Specific Device for the Detection of Adenomas</brief_title>
  <acronym>ENDOCOLES</acronym>
  <official_title>Evaluation of Colonoscopy With a Specific Device for the Detection of Adenomas: Multicenter, Prospective and Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Alberto Herreros de Tejada Echanojáuregui</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Clinical Research Network - CAIBER</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Puerta de Hierro University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of colonoscopy with a specific device for the detection of adenomas: Multicenter,
      prospective and randomized study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Given the discrepancy in the results of the published studies, the main objective of the
      present study would be to evaluate, through a multicentric design and with a sufficiently
      large sample of patients, if there are relevant differences in the ADR and in the MAP between
      the colonoscopy performed with a device specific (Endocuff visionTM) versus standard
      colonoscopy.

      Secondarily, the number of adenomas, the number of advanced adenomas and the number of
      serrated lesions in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 18, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Multicenter prospective trial with medical device</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Concealed assignation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma detection rate (ADR)</measure>
    <time_frame>1 day</time_frame>
    <description>Number of adenoma detected by colonoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean adenoma per procedure (MAP)</measure>
    <time_frame>1 day</time_frame>
    <description>Mean of adenoma detected by patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of adenomas detected by colonoscopy</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of advanced adenomas detected by colonoscopy</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of serrated lesions with or without detected dysplasia by colonoscopy</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1452</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Adenoma Colon</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colonoscopy with specific device with CE marking (Endocuff Vision)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colonoscopy with standard device of the center</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Patients undergoing screening colonoscopy</description>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_label>Active Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients must be adults (≥18 years), give their consent for endoscopic exploration, for
        the study and meet following inclusion criteria:

          1. Patients with positive immunologic fecal occult blood test (IFOBT) for population
             screening.

          2. Patients invited to an opportunistic screening colonoscopy or included regional
             population screening program.

          3. Patients with a family history of CRC and indication of screening colonoscopy.

          4. Patients with follow-up colonoscopy indication by personal history of adenomas.

        Exclusion Criteria:

          1. Patients with absolute contraindications for colonoscopy (suspicion of intestinal
             obstruction or perforation, acute diverticulitis suspected or confirmed 6 weeks before
             the colonoscopy, etc).

          2. Symptomatic patients with indication of diagnostic colonoscopy.

          3. Patients with a personal history of CRC.

          4. Patients with a personal history of chronic inflammatory bowel disease (IBD).

          5. Patients with a known personal history of hereditary CRC syndrome:

             I. No polyposis (Lynch syndrome). II. Polypic.

          6. Patients with suspected attenuated polyposis (&gt; 20 adenomas) with genetic diagnosis
             not defined.

          7. Patients with total or partial colic resection.

          8. Pregnant or breastfeeding mothers.

          9. Patients who have expressed their wish not to participate or who do not have the
             ability to understand and / or sign informed consent.

         10. Patients with any serious and uncontrolled medical, psychological, psychiatric,
             geographic or social problem that could interfere with the participation of the
             patient in the study or not allow an adequate follow-up and adherence with the
             protocol and evaluation of the results of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Herreros de Tejada, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Puerta de Hierro University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aurora Burgos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>La Paz University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario Puerta de Hierro - Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Hospital Universitario Fundacion Alcorcon</name>
      <address>
        <city>Madrid</city>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2018</study_first_submitted>
  <study_first_submitted_qc>February 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Puerta de Hierro University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Alberto Herreros de Tejada Echanojáuregui</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Adenoma</keyword>
  <keyword>Adenoma detection rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

